• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number U415034RX
Medical Device Problem Codes Leak/Splash (1354); Material Rupture (1546); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/01/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one ultraverse rx pta dilatation catheter was returned for evaluation.No specific anomalies were noted during the visual evaluation.During the functional testing, the balloon was inflated with the in-house presto inflation device, and water was noted to be leaking from the distal tip.Under microscopic observation, a tear on the rapid exchange port was noted.No further testing was performed.Therefore, the investigation into the reported balloon rupture remains inconclusive as the evidence of a balloon rupture couldn¿t be noted due to a leak on the catheter shaft upon inflating the returned balloon.However, the investigation confirmed the identified catheter leak, as the water was noted to be leaking from the distal tip upon inflating the balloon.The investigation was also confirmed for the identified hypotube tear, as during the microscopic observation, the tear was noted on the rapid exchange port.A definitive root cause for the reported balloon rupture, identified catheter leak and identified hypotube tear could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.Expiry date: 01/2025.
 
Event or Problem Description
It was reported that during an angioplasty procedure of a calcified target lesion of chronic total occlusion in the superficial femoral artery via a right contralateral approach, the pta balloon allegedly ruptured at 2 atm.The procedure was completed using another device.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAVERSE RX
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
CLEARSTREAM TECHNOLOGIES LTD.
moyne upper
enniscorthy, co. wexford N A
EI   N A
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16281955
Report Number2020394-2023-00022
Device Sequence Number5019835
Product Code LIT
UDI-Device Identifier00801741056802
UDI-Public(01)00801741056802
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K131199
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberU415034RX
Device Catalogue NumberU415034RX
Device Lot NumberCMGP0227
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/23/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/06/2023
Initial Report FDA Received Date02/02/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-